Ethanol ablation guided by sonographic appearance of the nodule is effective for treatment of primary hyperparathyroidism in dogs
Journal of the American Veterinary Medical Association · 2026
DOI: 10.2460/javma.26.02.0157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Veterinary Medical Association, 2026. Verfasst von Suzanne Schindler und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1Internal Medicine, MedVet, Cincinnati, OH. Hauptthemen laut MEDLINE: Ethanol, Dog Diseases, Hyperparathyroidism, Primary, Ablation Techniques. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy and safety of a modified percutaneous ultrasound-guided ethanol ablation technique for the treatment of primary hyperparathyroidism in dogs.
Methods
This prospective observational study was conducted at a single veterinary referral center. Dogs with persistent ionized hypercalcemia, normal/increased parathyroid hormone concentrations, normal/undetectable parathyroid hormone–related protein concentrations, and ultrasonographic identification of ≥ 1 presumed hyperfunctioning parathyroid nodule (≥ 2.5 mm) underwent percutaneous ultrasonographically guided ethanol ablation, in which ethanol was administered until real-time diffuse intralesional hyperechogenicity was achieved. Dogs with alternative causes of hypercalcemia were excluded. Data collected from October 2018 through April 2023 included signalment, lesion characteristics, ethanol volume administered, complications, and biochemical outcomes. Resolution of hypercalcemia following ablation was the primary outcome measure.
Results
49 dogs were enrolled, and follow-up data were available for 47. Hypercalcemia resolved in 42 of 47 dogs (89.4%). Complications occurred in 12 of 47 dogs (25.5%) and were classified as minor in 10 and major in 2. Dogs with resolution of hypercalcemia received a greater median volume of ethanol than dogs without resolution (0.60 mL [IQR, 0.30 to 1.00 mL] vs 0.15 mL [IQR, 0.09 to 0.37 mL]; P = .012). Ethanol volume was not associated with ethanol leakage severity or complication rates.
Conclusions
Sonographically guided ethanol ablation was an effective treatment for primary hyperparathyroidism in dogs, achieving resolution of hypercalcemia in nearly 90% of cases with a low rate of major complications. Clinical Relevance Ultrasound-guided ethanol ablation based on real-time nodule hyperechogenicity may be a practical alternative to volume-based protocols while maintaining efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Internal Medicine, MedVet, Cincinnati, OH.
- 2Radiology, MedVet, Cincinnati, OH.
ORCID-Profile: Michael Lane
Zitieren
APA
Schindler, S., Lane, M., Woodard, M., & Baron-Chapman, M. (2026). Ethanol ablation guided by sonographic appearance of the nodule is effective for treatment of primary hyperparathyroidism in dogs. Journal of the American Veterinary Medical Association. https://doi.org/10.2460/javma.26.02.0157
Vancouver
Schindler S, Lane M, Woodard M, Baron-Chapman M. Ethanol ablation guided by sonographic appearance of the nodule is effective for treatment of primary hyperparathyroidism in dogs. Journal of the American Veterinary Medical Association. 2026. doi:10.2460/javma.26.02.0157
BibTeX
@article{Schindler2026,
author = {Schindler, Suzanne and Lane, Michael and Woodard, Morgan and Baron-Chapman, Matt},
title = {Ethanol ablation guided by sonographic appearance of the nodule is effective for treatment of primary hyperparathyroidism in dogs},
journal = {Journal of the American Veterinary Medical Association},
year = {2026},
doi = {10.2460/javma.26.02.0157}
}
EUVIMED